Literature DB >> 26722842

Induction of Endothelial Phenotype From Wharton's Jelly-Derived MSCs and Comparison of Their Vasoprotective and Neuroprotective Potential With Primary WJ-MSCs in CA1 Hippocampal Region Ex Vivo.

Patrycja Obtulowicz1, Wioletta Lech, Lukasz Strojek, Anna Sarnowska, Krystyna Domanska-Janik.   

Abstract

Ischemic stroke results in violent impairment of tissue homeostasis leading to severe perturbation within the neurovascular unit (NVU) during the recovery period. The aim of this study was to assess the potential of mesenchymal stem cells (MSCs) originating from Wharton's jelly (WJ) to differentiate into functionally competent cells of endothelial lineage (WJ-EPCs). The protective effect(s) of either primary WJ-MSCs or induced WJ-EPCs was investigated and compared after oxygen-glucose deprivation (OGD) of hippocampal organotypic slices (OHC) in the indirect coculture model. WJ-MSCs, primed in EGM-2 (Lonza commercial medium) under 5% O2, acquired cobblestone endothelial-like morphology, formed capillary-like structures and actively took up DiI-Ac-LDL. Both cell types (WJ-MSCs and WJ-EPCs) were positive for CD73, CD90, CD105, VEGFR-2, and VEGF, but only endothelial-like culture expressed vWF and PECAM-1 markers at significant levels. In the presence of either WJ-MSCs or WJ-EPCs in the compartment below OGD-injured slices, cell death and vascular atrophy in the hypoxia-sensitive CA1 region were substantially decreased. This suggests that a paracrine mechanism may mediate WJ-MSC- and WJ-EPC-dependent protection. Thus, finally, we estimated secretion of the neuro/angio/immunomodulatory molecules IL-6, TGF-β1, and VEGF by these cell cultures. We have found that release of TGF-β1 and IL-6 was TLR ligand [LPS and Poly(I:C)] concentration dependent and stronger in WJ-EPC than WJ-MSC cultures. Simultaneously, the uneven pattern of TLR receptors and modulatory cytokine gene expression was confirmed also on qRT-PCR level, but no significant differences were noticed between WJ-EPC and primary WJ-MSC cultures.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26722842     DOI: 10.3727/096368915X690369

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  11 in total

Review 1.  Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment.

Authors:  Saeid Bagheri-Mohammadi
Journal:  Cell Tissue Bank       Date:  2021-01-04       Impact factor: 1.522

Review 2.  Interaction of Neural Stem Cells (NSCs) and Mesenchymal Stem Cells (MSCs) as a Promising Approach in Brain Study and Nerve Regeneration.

Authors:  Agnieszka Kaminska; Klaudia Radoszkiewicz; Paulina Rybkowska; Aleksandra Wedzinska; Anna Sarnowska
Journal:  Cells       Date:  2022-04-26       Impact factor: 7.666

3.  Resveratrol promotes hUC-MSCs engraftment and neural repair in a mouse model of Alzheimer's disease.

Authors:  Xinxin Wang; Shanshan Ma; Bo Yang; Tuanjie Huang; Nan Meng; Ling Xu; Qu Xing; Yanting Zhang; Kun Zhang; Qinghua Li; Tao Zhang; Junwei Wu; Greta Luyuan Yang; Fangxia Guan; Jian Wang
Journal:  Behav Brain Res       Date:  2017-11-02       Impact factor: 3.332

4.  Neuroprotective Potential and Paracrine Activity of Stromal Vs. Culture-Expanded hMSC Derived from Wharton Jelly under Co-Cultured with Hippocampal Organotypic Slices.

Authors:  Sylwia Dabrowska; Joanna Sypecka; Anna Jablonska; Lukasz Strojek; Miroslaw Wielgos; Krystyna Domanska-Janik; Anna Sarnowska
Journal:  Mol Neurobiol       Date:  2017-11-13       Impact factor: 5.590

5.  Bone Defect Repair Using a Bone Substitute Supported by Mesenchymal Stem Cells Derived from the Umbilical Cord.

Authors:  Michal Kosinski; Anna Figiel-Dabrowska; Wioletta Lech; Lukasz Wieprzowski; Ryszard Strzalkowski; Damian Strzemecki; Lukasz Cheda; Jacek Lenart; Krystyna Domanska-Janik; Anna Sarnowska
Journal:  Stem Cells Int       Date:  2020-04-05       Impact factor: 5.443

6.  Biomimetic microenvironmental preconditioning enhance neuroprotective properties of human mesenchymal stem cells derived from Wharton's Jelly (WJ-MSCs).

Authors:  Wioletta Lech; Anna Sarnowska; Zuzanna Kuczynska; Filip Dabrowski; Anna Figiel-Dabrowska; Krystyna Domanska-Janik; Leonora Buzanska; Marzena Zychowicz
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

7.  Mesenchymal Stem Cell-Conditioned Medium Protects Hippocampal Neurons From Radiation Damage by Suppressing Oxidative Stress and Apoptosis.

Authors:  Yue Huang; Xiaolong Mei; Weishi Jiang; Hui Zhao; Zhenyu Yan; Haixia Zhang; Ying Liu; Xia Hu; Jingyi Zhang; Wenshuo Peng; Jing Zhang; Qingling Qi; Naiyao Chen
Journal:  Dose Response       Date:  2021-02-27       Impact factor: 2.658

8.  Neuroprotective Action of Human Wharton's Jelly-Derived Mesenchymal Stromal Cell Transplants in a Rodent Model of Stroke.

Authors:  Kuo-Jen Wu; Seong-Jin Yu; Chia-Wen Chiang; Yu-Wei Lee; B Linju Yen; Pei-Chi Tseng; Chun-Sen Hsu; Li-Wei Kuo; Yun Wang
Journal:  Cell Transplant       Date:  2018-10-04       Impact factor: 4.064

Review 9.  Wharton' jelly mesenchymal stromal cell therapy for ischemic brain injury.

Authors:  Kuo-Jen Wu; Seong-Jin Yu; Chia-Wen Chiang; Yu-Wei Lee; B Linju Yen; Chun-Sen Hsu; Li-Wei Kuo; Yun Wang
Journal:  Brain Circ       Date:  2018-10-09

Review 10.  Stem Cell Therapies for Cerebral Palsy and Autism Spectrum Disorder-A Systematic Review.

Authors:  Justyna Paprocka; Konrad Kaminiów; Sylwia Kozak; Karolina Sztuba; Ewa Emich-Widera
Journal:  Brain Sci       Date:  2021-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.